Thiruvananthapuram: Kerala became the first state in India to get a nod from the Indian Council of Medical Research (ICMR) to conduct plasma therapy to cure COVID-19. On this occasion, ETV Bharat speaks to Dr Asha of Sree Chitra Tirunal Institute for Medical Sciences and Technology on the various aspects of plasma therapy and the way forward.
Transfusion department of the Sree Chitra Institute in the State capital will soon begin clinical trials on critically ill COVID-19 patients.
The convalescent plasma therapy is based on the inference that the antibodies isolated from the plasma of the patients who have completely recovered from COVID-19 infection can help improve the status of ill COVID-19 patients.
Speaking to ETV Bharat, Dr Asha, Director, Sree Chitra Tirunal Institute for Medical Sciences and Technology said that Kerala got the approval to conduct a clinical trial on harvesting convalescent plasma using plasmapheresis.
Read:'We shall overcome': Kerala proudly announces to the world